LUNG
LUNG
NASDAQ · Health Care

Pulmonx Corp

$2.25
+0.09 (+4.17%)
As of Aug 15, 2:22 AM ET ·
Financial Highlights (FY 2026)
Revenue
95.32M
Net Income
-56,878,556
Gross Margin
74.2%
Profit Margin
-59.7%
Rev Growth
+19.0%
D/E Ratio
0.69
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.2% 74.2% 64.5% 64.5%
Operating Margin -59.3% -53.4% 14.2% 15.2%
Profit Margin -59.7% -56.7% 13.0% 12.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 95.32M 80.08M 18.36M 19.89M
Gross Profit 70.72M 59.41M 11.85M 12.83M
Operating Income -56,523,302 -42,737,941 2.61M 3.02M
Net Income -56,878,556 -43,006,553 2.39M 2.44M
Gross Margin 74.2% 74.2% 64.5% 64.5%
Operating Margin -59.3% -53.4% 14.2% 15.2%
Profit Margin -59.7% -56.7% 13.0% 12.3%
Rev Growth +19.0% +19.0% -0.5% +20.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 19.61M 19.61M 22.81M 25.99M
Total Equity 28.60M 28.60M 28.06M 25.55M
D/E Ratio 0.69 0.69 0.81 1.02
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -55,412,990 -44,226,111 3.71M 4.15M
Free Cash Flow 1.86M 2.73M